MedTrace Logo

Сohort Study to Evaluate Exacerbations, Respiratory Symptoms, Physical Exercise Intolerance and Lung Functions Among Participants Who Use IQOS With Heatsticks Compared to Smokers of Conventional Cigarettes

NCT03383601 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2023-12-15

No results posted yet for this study

Summary

This study evaluates frequency of exacerbations, respiratory symptoms, physical exercise intolerance and abnormal lung functions among participants who use IQOS with heatsticks compared to smokers of conventional cigarettes

Conditions

  • Pulmonary Disease, Chronic Obstructive
  • Respiratory Insufficiency
  • Physical Disability
  • Respiratory Disease

Interventions

OTHER

Heated Tobacco product IQOS/heatstick

Heated Tobacco Products: heatsticks heated by iQOS device

OTHER

Smoking combustible cigarettes

Current smoking of combustible cigarettes

Sponsors & Collaborators

  • Philip Morris International

    collaborator INDUSTRY

  • Synergy Research Group

    collaborator INDUSTRY

  • HealthCity LLP

    collaborator UNKNOWN

  • Kazakhstan Academy of Preventive Medicine

    lead OTHER

Principal Investigators

  • Almaz Sharman, MD, PhD · Kazakhstan Academy of Preventive Medicine

Eligibility

Min Age
40 Years
Max Age
59 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-16
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • Kazakhstan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03383601 on ClinicalTrials.gov